Page 5 - Special Access News Today

The wholly-owned Creso Pharma subsidiary is currently conducting clinical trials of its synthetic psilocybin formulation as treatment for mental health conditions NEDLANDS, Australia, Feb. 9, 2023 /PRNewswire/ --Creso Pharma Limited(ASX:CPH, FRA:1X8) ('Creso Pharma') is pleased to announce its wholly-owned psychedelics subsidiary, Halucenex Life Sciences Inc. ('Halucenex'), is exploring opportunities to register its synthetic psilocybin formulation for the Australian market follo...

07.02.2023 - The initial line of Viola-branded products will include proprietary formulations in vaporizer formats for patients with medical authorizations through the Special Access Program. The prescription products will be commercialized in partnership with ... Seite 1

Avicanna Inc (TSX:AVCN, OTCQX:AVCNF) announced that it has entered into a new sub-license agreement with VB Brands California LLC (Viola Brands) and Player...

Thomas Hartle has end-of-life anxiety stemming from a terminal cancer diagnosis, and in 2020, the 54-year-old became the first person in Canada to legally gain access to psilocybin-assisted therapy to deal with it.

Around Australia and the world, scientists, psychiatrists and CEOs are mapping out the potential of psychedelics. But not everyone’s on the same page.

Thomas Hartle, a Saskatoon man with terminal cancer, hopes he can legally continue using magic mushrooms to cope with his fear of dying.

Swifties are convinced a ticket sale screwed them over. Bring out the charts.

One of the easiest ways that governments can exert control over us is by withholding information from each and every one

Remember that announcement that Tyra Banks made during Disney+ Night on "Dancing with the Stars" about a special access shopDisney site? It's been removed from the streaming version of the episode as the website updates with a "Coming soon" message.

DOJ is moving at a shockingly fast pace, so fast that Trump's advisers are in a panicked meltdown.